MCID: NRR001
MIFTS: 46

Neuroretinitis

Categories: Neuronal diseases, Eye diseases

Aliases & Classifications for Neuroretinitis

MalaCards integrated aliases for Neuroretinitis:

Name: Neuroretinitis 12 14 69
Juxtapapillary Focal Retinitis and Retinochoroiditis 12 69
Retinitis 41 69
Focal Retinitis and Retinochoroiditis, Juxtapapillary 12
Papilloretinitis 12

Classifications:



External Ids:

Disease Ontology 12 DOID:10176
ICD10 32 H30.9
MeSH 41 D012173
SNOMED-CT 64 410471004

Summaries for Neuroretinitis

MalaCards based summary : Neuroretinitis, also known as juxtapapillary focal retinitis and retinochoroiditis, is related to toxocariasis and secondary syphilis. An important gene associated with Neuroretinitis is CD40LG (CD40 Ligand). The drugs 4-Aminopyridine and Dopamine have been mentioned in the context of this disorder. Affiliated tissues include heart, brain and breast, and related phenotypes are homeostasis/metabolism and hematopoietic system

Wikipedia : 72 Cat-scratch disease (CSD) is a common and usually benign infectious disease caused by the bacterium... more...

Related Diseases for Neuroretinitis

Diseases related to Neuroretinitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 152)
# Related Disease Score Top Affiliating Genes
1 toxocariasis 30.6 CD40LG RNASE3
2 secondary syphilis 30.2 CD40LG EXTL3
3 recurrent idiopathic neuroretinitis 12.0
4 irvan syndrome 11.9
5 early yaws 10.6 CD40LG EXTL3
6 syphilitic meningitis 10.6 CD40LG EXTL3
7 optic papillitis 10.6 CD40LG EXTL3
8 primary syphilis 10.6 CD40LG EXTL3
9 chronic interstitial cystitis 10.6 CD40LG RNASE3
10 tertiary syphilis 10.6 CD40LG EXTL3
11 latent syphilis 10.6 CD40LG EXTL3
12 congenital syphilis 10.5 CD40LG EXTL3
13 loeffler syndrome 10.5 ACE CD40LG
14 chorioretinitis 10.5 CD40LG EXTL3
15 asymptomatic neurosyphilis 10.5 CD40LG EXTL3
16 vasomotor rhinitis 10.5 CD40LG RNASE3
17 urethritis 10.5 CD40LG EXTL3
18 vaginal discharge 10.5 EXTL3 FLNA
19 retinitis 10.5
20 cervix disease 10.5 CD40LG FLNA
21 vasculogenic impotence 10.5 ACE RNASE3
22 neuronitis 10.4 CD40LG TNFRSF10A
23 panencephalitis, subacute sclerosing 10.4 CD40LG MOG
24 cerebral sarcoidosis 10.4 ACE LYZ
25 geniculate herpes zoster 10.4 CD40LG TNFRSF10A
26 zika fever 10.4 CD40LG IFNB1
27 diffuse glomerulonephritis 10.4 CD40LG LYZ
28 vasculitis 10.4
29 retinal vasculitis 10.4
30 vaginal disease 10.4 EXTL3 FLNA
31 aneurysm 10.4
32 hypertensive nephropathy 10.4 ACE VEGFA
33 acute proliferative glomerulonephritis 10.4 CD40LG LYZ
34 ancylostomiasis 10.4 CD40LG RNASE3
35 neurogenic bowel 10.4 AQP4 CA2
36 subdural empyema 10.3 ACE FLNA
37 acute disseminated encephalomyelitis 10.3 AQP4 MOG
38 respiratory system disease 10.3 ACE CD40LG RNASE3
39 transient arthritis 10.3 CD40LG TNFRSF10A
40 acute hemorrhagic leukoencephalitis 10.3 AQP4 VEGFA
41 central nervous system vasculitis 10.3 CD40LG TNFRSF10A
42 cat-scratch disease 10.3
43 spinal cord disease 10.3 AQP4 CD40LG MOG
44 herpes gestationis 10.3 CD40LG RNASE3 TNFRSF10A
45 hypersensitivity reaction type iv disease 10.3 ACE CD40LG LYZ
46 pyelitis 10.3 CD40LG LYZ
47 retinal hemangioblastoma 10.2 CA2 LYZ VEGFA
48 urinary system disease 10.2 ACE CD40LG LYZ
49 cancer-associated retinopathy 10.2 RCVRN VEGFA
50 hypersensitivity reaction disease 10.2 ACE CD40LG TNFRSF10A

Graphical network of the top 20 diseases related to Neuroretinitis:



Diseases related to Neuroretinitis

Symptoms & Phenotypes for Neuroretinitis

MGI Mouse Phenotypes related to Neuroretinitis:

43
# Description MGI Source Accession Score Top Affiliating Genes
1 homeostasis/metabolism MP:0005376 10.06 IFNB1 AQP4 LYZ CA2 TNFRSF10A CD40LG
2 hematopoietic system MP:0005397 10.02 ACE IFNB1 AQP4 LYZ MOG TNFRSF10A
3 endocrine/exocrine gland MP:0005379 10.01 ACE AQP4 LYZ CA2 TNFRSF10A CD40LG
4 immune system MP:0005387 9.96 AQP4 LYZ CA2 MOG TNFRSF10A CD40LG
5 nervous system MP:0003631 9.81 IFNB1 AQP4 LYZ CA2 MOG CD40LG
6 no phenotypic analysis MP:0003012 9.43 IFNB1 AQP4 LYZ TNFRSF10A UBL4A VEGFA
7 renal/urinary system MP:0005367 9.1 ACE AQP4 LYZ CA2 CD40LG VEGFA

Drugs & Therapeutics for Neuroretinitis

Drugs for Neuroretinitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 411)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
4-Aminopyridine Approved Phase 4 504-24-5 1727
2
Dopamine Approved Phase 4 51-61-6, 62-31-7 681
3
Droperidol Approved, Vet_approved Phase 4 548-73-2 3168
4
Gabapentin Approved, Investigational Phase 4,Phase 3 60142-96-3 3446
5
Ketamine Approved, Vet_approved Phase 4,Phase 1 6740-88-1 3821
6
Lidocaine Approved, Vet_approved Phase 4,Phase 2 137-58-6 3676
7
Azithromycin Approved Phase 4 83905-01-5 53477736 447043 55185
8
Prednisone Approved, Vet_approved Phase 4,Phase 3 53-03-2 5865
9
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4,Early Phase 1 437-38-7 3345
10
Midazolam Approved, Illicit Phase 4,Phase 1 59467-70-8 4192
11
Propofol Approved, Investigational, Vet_approved Phase 4 2078-54-8 4943
12
Bupivacaine Approved, Investigational Phase 4 38396-39-3, 2180-92-9 2474
13
Doxycycline Approved, Investigational, Vet_approved Phase 4 564-25-0 54671203
14
Lymecycline Approved, Investigational Phase 4 992-21-2 5280963
15
Tetracycline Approved, Vet_approved Phase 4 60-54-8 5353990
16
Aluminum hydroxide Approved, Investigational Phase 4 21645-51-2
17
Neomycin Approved, Vet_approved Phase 4 1404-04-2 8378
18
Aripiprazole Approved, Investigational Phase 4 129722-12-9 60795
19
Imipramine Approved Phase 4 50-49-7 3696
20
Pregabalin Approved, Illicit, Investigational Phase 4 148553-50-8 5486971
21
Morphine Approved, Investigational Phase 4,Phase 3 57-27-2 5288826
22
Clozapine Approved Phase 4 5786-21-0 2818
23
Insulin Detemir Approved Phase 4 169148-63-4 5311023
24
Zinc Approved, Investigational Phase 4 7440-66-6 32051 23994
25
Capsaicin Approved Phase 4 404-86-4 1548943
26
Estradiol Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2 50-28-2 5757
27
Everolimus Approved Phase 4,Phase 2 159351-69-6 6442177
28
Sirolimus Approved, Investigational Phase 4,Phase 2 53123-88-9 46835353 6436030 5284616
29
Levonorgestrel Approved, Investigational Phase 4 797-63-7, 17489-40-6 13109
30
Methylprednisolone Approved, Vet_approved Phase 4,Phase 2,Phase 3 83-43-2 6741
31
Prednisolone Approved, Vet_approved Phase 4,Phase 2,Phase 3 50-24-8 5755
32
Isoniazid Approved, Investigational Phase 4,Phase 3 54-85-3 3767
33
Rifampin Approved Phase 4,Phase 3,Phase 2 13292-46-1 5381226 5458213
34
Rifapentine Approved, Investigational Phase 4,Phase 2 61379-65-5 6323497
35
Tamoxifen Approved Phase 4 10540-29-1 2733526
36
Metformin Approved Phase 4,Phase 2,Phase 1 657-24-9 4091 14219
37
Ciprofloxacin Approved, Investigational Phase 4 85721-33-1 2764
38
Piperacillin Approved Phase 4 66258-76-2 43672
39
Tazobactam Approved Phase 4 89786-04-9 123630
40
Methylnaltrexone Approved Phase 4 916055-93-1, 83387-25-1 6603824
41
Naltrexone Approved, Investigational, Vet_approved Phase 4 16590-41-3 5360515
42
Ticagrelor Approved Phase 4 274693-27-5 9871419
43
Furosemide Approved, Vet_approved Phase 4,Phase 1 54-31-9 3440
44
Haloperidol Approved Phase 4 52-86-8 3559
45
Paclitaxel Approved, Vet_approved Phase 4 33069-62-4 36314
46
Caffeine Approved, Nutraceutical Phase 4,Phase 1 58-08-2 2519
47
Calcitriol Approved, Nutraceutical Phase 4 32222-06-3 5280453 134070
48
Cholecalciferol Approved, Nutraceutical Phase 4,Phase 2,Phase 3 67-97-0 10883523 5280795 6221
49
Ergocalciferol Approved, Nutraceutical Phase 4,Phase 2,Phase 3 50-14-6 5280793
50
Vitamin D Approved, Nutraceutical, Vet_approved Phase 4,Phase 2,Phase 3 1406-16-2

Interventional clinical trials:

(show top 50) (show all 394)

# Name Status NCT ID Phase Drugs
1 Resistance Training and Amino Pyridine in Multiple Sclerosis Unknown status NCT02143167 Phase 4 SR-fampridine;Placebo
2 Comforting Conversation During Colonoscopy: A Trial on Patient Satisfaction Unknown status NCT02484105 Phase 4
3 Optimal Multimodal Analgesia in Laparoscopic Cholecystectomy Unknown status NCT00209885 Phase 4 Gabapentin;S-ketamine;Lidocaine;Droperidol
4 Optimal Multimodal Analgesia in Abdominal Hysterectomy Unknown status NCT00209872 Phase 4 Gabapentin;Lidocaine;S-ketamine
5 The Efficacy of Prednisone and Azithromycin in the Treatment of Patients With Cat Scratch Disease Unknown status NCT01469702 Phase 4 prednison and azithromycin;prednison, azithromycin;prednison, Azenil
6 SCRIPPS V: Intracoronary Brachytherapy for Recurrent Restenosis After Multiple Drug-Eluting Stents Unknown status NCT00714545 Phase 4
7 Nurse Administered Propofol Sedation vs. Midazolam With Fentanyl-sedation for Flexible Bronchoscopy: A Randomized, Single Blind, Controlled Study of Satisfaction and Safety. Unknown status NCT02226328 Phase 4 Propofol sedation;Midazolam and Fentanyl sedation
8 Ultrasound-guided Ilioinguinal-iliohypogastric Block for Inguinal Hernia Repair Unknown status NCT01326039 Phase 4 bupivacaine;saline
9 Time to Eradication of Mycoplasma Genitalium and Chlamydia Trachomatis After Treatment Commenced Unknown status NCT01661985 Phase 4 Azithromycin;Doxycycline;lymecycline
10 Fractional Flow Reserve Versus Angiography Randomization for Graft Optimization Trial Unknown status NCT02477371 Phase 4
11 Cellular Immunity in Adult Hepatitis B-vaccinated Serologic Non-responders Unknown status NCT01451801 Phase 4
12 Tolerance and Effect of Antipsychotics in Children and Adolescents With Psychosis Unknown status NCT01119014 Phase 4 Aripiprazole;Quetiapine
13 Imipramine and Pregabalin Combination in Painful Polyneuropathy Unknown status NCT01047488 Phase 4 Imipramine;Pregabalin;Imipramine, pregabalin;Placebo
14 Comparative Study on Self-adhesive Mesh for Open Inguinal Hernia Repair Unknown status NCT00960011 Phase 4
15 The Significance of Deviation in Time From the 12-hour Standard Serum-clozapine Monitoring. Completed NCT02625103 Phase 4 Clozapine
16 Pain Relieving Efficacy of TAP Block in Patients After Laparoscopic Gastric Bypass. Completed NCT01308554 Phase 4 Placebo: sterile normal saline;Marcaine
17 Santyl vs. Sharp Debridement of Diabetic Foot Wounds Completed NCT01056198 Phase 4 Santyl
18 Effects of Insulin Detemir and NPH Insulin on Renal Handling of Sodium, Fluid Retention, and Weight in Type 2 Diabetic Patients Completed NCT00742976 Phase 4 Insulin Detemir; Insulin Insulatard;Insulin Detemir, Insulin Insulatard
19 FAME - Fampyra Outcome Measures Study: a Study of Different Outcome Measures on the Effect of Fampyra Completed NCT01656148 Phase 4 Fampridine-SR
20 Effects of NSK-SD (Nattokinase) on Blood Pressure Completed NCT02886507 Phase 4
21 The Effect of Caffeine in Elderly Citizen Following Eight Hour Abstinence From Caffeine Containing Drinks & Foods Completed NCT01048515 Phase 4 Caffeine
22 Satisfaction With Nurse Administered Propofol Sedation vs. Midazolam With Fentanyl Sedation for Endoscopy Completed NCT01934088 Phase 4 Propofol;Midazolam;Fentanyl
23 Bilateral Dual TAP Block: Description of a Novel Four-point Approach Completed NCT01040234 Phase 4
24 Sensory Examination and Pharmacological Modulation of Oral Hyperexcitability in Patients With Atypical Odontalgia and Matched Healthy Controls Completed NCT00115102 Phase 4 fentanyl;S-ketamine
25 The Effect of Calcium and Vitamin D in Patients With Heart Failure Completed NCT00497900 Phase 4 Vitamin D
26 Danish Osteoporosis Prevention Study Completed NCT00252408 Phase 4 Hormone replacement therapy
27 Defining the Optimal Hormonal Replacement Therapy in Turner Syndrome Completed NCT00134745 Phase 4 estradiol
28 The SORT OUT IX STEMI OCT Trial Recruiting NCT02915107 Phase 4
29 Tamoxifen to Reduce Unscheduled Bleeding in New Users of the Levonorgestrel-releasing Intrauterine System (LNG-IUS) Recruiting NCT02824224 Phase 4 Tamoxifen;Placebo (for Tamoxifen)
30 Corticosteroid Reduction in COPD Recruiting NCT02857842 Phase 4 Prednisolone
31 Metformin Pharmacokinetics in Patients With Chronic and Acute Heart Failure Recruiting NCT02797340 Phase 4 Metformin
32 Targeted AntiBiotics for Chronic Obstructive Pulmonary Disease Recruiting NCT03262142 Phase 4 Piperacillin/tazobactam;Ciprofloxacin
33 Methylnaltrexone as a Method to Improve Ticagrelor Uptake in Morphine Treated STEMI Patients Recruiting NCT02942550 Phase 4 Methylnaltrexone bromide (Relistor®).;Sodium Chloride 9mg/mL
34 Treatment of Latent Tuberculosis in Socially Marginalised Citizens Recruiting NCT03266991 Phase 4 Rifapentine;Isoniazid
35 Ultibro® Versus Spiriva® Alone to Reduce Exertional Dyspnea in Patients With Moderate to Severe COPD Recruiting NCT02567214 Phase 4 Ultibro®;Spiriva®
36 Study on the Effect of Influenza Vaccination After Heart Attack on Future Cardiovascular Prognosis Recruiting NCT02831608 Phase 4
37 Pan European Collaboration on Antipsychotic Naïve Schizophrenia II Recruiting NCT02339844 Phase 4 Aripiprazole
38 Vaccine Campaign Effects on General Hospital Admissions and Mortality Among Children Recruiting NCT03460002 Phase 4
39 BIOFREEDOM Stent Versus ORSIRO Stent: SORT OUT IX Active, not recruiting NCT02623140 Phase 4
40 The COOPerative Establishment for Necessary Investigation in Clinical Outcome After Stenting Not yet recruiting NCT01534221 Phase 4
41 Agents Intervening Against Delirium in Intensive Care Unit Not yet recruiting NCT03392376 Phase 4 Haloperidol Injection
42 The Treatment of Coronary De-novo Lesions With the Elutax Paclitaxel-eluting Balloon Alone, a Pilot Study Terminated NCT01899235 Phase 4
43 Forced Fluid Removal in High Risk Acute Kidney Injury Terminated NCT02458157 Phase 4 Furosemide (Furix)
44 Morphine, Dyspnea, Exercise and COPD Unknown status NCT01718496 Phase 3 Morphine;Placebo
45 Trial for Single Port Versus Conventional Laparoscopic Colectomy Unknown status NCT01101672 Phase 2, Phase 3
46 Adjuvant Whole Breast Radiotherapy (RT) With Intensity Modulated Radiotherapy (IMRT) and a Simultaneous Integrated Boost Versus Conventional RT and a Sequential Boost Unknown status NCT01322854 Phase 3
47 Lung Protective Ventilation During Robotic Assisted Prostatectomy Completed NCT02551341 Phase 3
48 Nucleoplasty for Contained Herniated Lumbar Discs Completed NCT00124774 Phase 3
49 Vitamin D Supplementation and Male Infertility: The CBG-study a Randomized Clinical Trial Completed NCT01304927 Phase 2, Phase 3 Cholecalciferol and calcium
50 The Effect of the GLP-1 Analogue Exenatide on Type 2 Diabetes in CNS and Heart During Hyperglycemia Assessed by PET Completed NCT00747968 Phase 2, Phase 3 Byetta, Exenatide

Search NIH Clinical Center for Neuroretinitis

Cochrane evidence based reviews: retinitis

Genetic Tests for Neuroretinitis

Anatomical Context for Neuroretinitis

MalaCards organs/tissues related to Neuroretinitis:

38
Heart, Brain, Breast, Liver, Spinal Cord, Testes, Bone

Publications for Neuroretinitis

Articles related to Neuroretinitis:

(show top 50) (show all 305)
# Title Authors Year
1
Pathogenesis of idiopathic retinal vasculitis, aneurysms, and neuroretinitis (IRVAN) or 'idiopathic retinal arteriolar aneurysms (IRAA)' with macular star. ( 29447942 )
2018
2
Multimodal imaging questions etiology of idiopathic retinal vasculitis, aneurysms and neuroretinitis syndrome (IRVAN syndrome). ( 29406987 )
2018
3
Diffuse Unilateral Subacute Neuroretinitis Caused by Ancylostoma Hookworm. ( 28098549 )
2017
4
Neuroretinitis Secondary to Bartonella Henselae in a Patient with Myelinated Retinal Nerve Fibers: Diagnostic Dilemmas and Treatment. ( 29283743 )
2017
5
A case of suspected symptomatic Zika Neuroretinitis. ( 28736717 )
2017
6
Optical coherence tomography angiography of diffuse unilateral subacute neuroretinitis. ( 29260087 )
2017
7
Idiopathic Retinal Vasculitis, Aneurysms, and Neuroretinitis Syndrome Presenting With Branch Retinal Artery Occlusion. ( 29121367 )
2017
8
Neuroretinal evaluation using optical coherence tomography in patients affected by pituitary tumors. ( 28447589 )
2017
9
TREATMENT OF IDIOPATHIC RETINAL VASCULITIS, ANEURYSMS, AND NEURORETINITIS (IRVAN) WITH PHOTOCOAGULATION IN COMBINATION WITH SYSTEMIC IMMUNOSUPPRESSION. ( 29261555 )
2017
10
Optical Coherence Tomography in Neuroretinitis: Epipapillary Infiltrates and Retinal Folds. ( 28418948 )
2017
11
Unilateral neuroretinitis. ( 28416231 )
2017
12
Neuroretinitis as presenting and the only presentation of Lyme disease: Diagnosis and management. ( 28440258 )
2017
13
Ultrawide field imaging with navigable magnifier for diagnosis of diffuse unilateral subacute neuroretinitis. ( 29269373 )
2017
14
Full-thickness macular hole: a rare complication of Borrelia burgdorferi neuroretinitis. ( 28473358 )
2017
15
Idiopathic retinal vasculitis, aneurysms, and neuroretinitis (IRVAN) syndrome: clinical perspectives. ( 29062224 )
2017
16
UNILATERAL NEURORETINITIS AS A LATE-ONSET MANIFESTATION OF THE CHIKUNGUNYA FEVER: A CASE SERIES. ( 28957957 )
2017
17
BARTONELLA HENSELAE NEURORETINITIS ASSOCIATED WITH CENTRAL RETINAL VEIN OCCLUSION, CHOROIDAL ISCHEMIA, AND ISCHEMIC OPTIC NEUROPATHY. ( 28700390 )
2017
18
Vanishing retinal arterial aneurysms with anti-tubercular treatment in a patient presenting with idiopathic retinal vasculitis, aneurysms, and neuroretinitis. ( 26922651 )
2016
19
Successful Management of Diffuse Unilateral Subacute Neuroretinitis with Anthelmintics, and Intravitreal Triamcinolone followed by Laser Photocoagulation. ( 27195096 )
2016
20
Toxoplasmosis Neuroretinitis: A Case Report. ( 27340559 )
2016
21
Fluorescein Photodiagnosis of Idiopathic Retinal Vasculitis, Aneurysms, and Neuroretinitis (IRVAN) Syndrome: A Case Report and Long-Term Outcome of Photocoagulation Therapy. ( 27491854 )
2016
22
BARTONELLA QUINTANA-ASSOCIATED NEURORETINITIS: LONGITUDINAL SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHIC FINDINGS. ( 27258542 )
2016
23
Choroidal neovascularization complicating optic disc drusen, mistaken for Bartonella neuroretinitis. ( 27730317 )
2016
24
Bilateral neovascular glaucoma in idiopathic retinal vasculitis, aneurysms, and neuroretinitis syndrome. ( 27085273 )
2016
25
Bilateral neuroretinitis and anterior uveitis following ipilimumab treatment for metastatic melanoma. ( 27165193 )
2016
26
Diffuse Unilateral Subacute Neuroretinitis From Raccoon Exposure Resistant to Laser Photocoagulation. ( 27434904 )
2016
27
Epstein-Barr Virus Neuroretinitis in a Lung Transplant Patient. ( 27525478 )
2016
28
Bilateral Neuroretinitis and a Unilateral Superior Hemivein Occlusion with Frosted Branch Angiitis Pattern Presenting Simultaneously in BehAset's Disease. ( 27065852 )
2016
29
Neuroretinitis with dual infections. ( 26527902 )
2015
30
An Alternative Diagnosis: Bartonella Neuroretinitis. ( 26292952 )
2015
31
Systemic Lupus Erythematosus Presenting as Neuroretinitis. ( 27608700 )
2015
32
Idiopathic Retinal Vasculitis, Aneurysms, and Neuroretinitis Syndrome. ( 26441263 )
2015
33
An Atypical Presentation of Bartonella Neuroretinitis. ( 26447400 )
2015
34
Bilateral stellate neuroretinitis revealing a pheochromocytoma. ( 25995810 )
2015
35
The natural history of idiopathic neuroretinitis. ( 26116629 )
2015
36
Lyme disease associated neuroretinitis - Case report. ( 26689876 )
2015
37
Final Diagnosis in Patients Referred with a Diagnosis of Neuroretinitis. ( 27928367 )
2015
38
Neuroretinitis in ocular bartonellosis. ( 25453244 )
2015
39
Re: An Alternative Diagnosis: Bartonella Neuroretinitis. ( 26292953 )
2015
40
A rare case of idiopathic retinal vasculitis, aneurysms and neuroretinitis (IRVAN) syndrome. ( 26265851 )
2015
41
Optical Coherence Tomography Features in Idiopathic Retinal Vasculitis, Aneurysms and Neuroretinitis Syndrome. ( 26425325 )
2015
42
Clinical experience in treatment of diffuse unilateral subretinal neuroretinitis. ( 26491239 )
2015
43
Teaching NeuroImages: Cat-scratch optic neuropathy without neuroretinitis. ( 26078406 )
2015
44
Diffuse unilateral subacute neuroretinitis in a healthy Korean male: the first case report in Korea. ( 25729261 )
2015
45
GFAP antibodies show protective effect on oxidatively stressed neuroretinal cells via interaction with ERP57. ( 25837926 )
2015
46
Atypical neuroretinitis in secondary chickenpox. ( 25950465 )
2015
47
Full-thickness macular hole in Bartonella henselae neuroretinitis in an 11-year-old girl. ( 25709274 )
2015
48
Dynamics of intraretinal fluid accumulation evidenced by SD-OCT in a case of cat scratch neuroretinitis. ( 24625384 )
2014
49
Unilateral neuroretinitis secondary to Bartonella henselae infection. ( 24106074 )
2014
50
Phaeochromocytoma revealed by a stellate neuroretinitis. ( 25182462 )
2014

Variations for Neuroretinitis

Expression for Neuroretinitis

Search GEO for disease gene expression data for Neuroretinitis.

Pathways for Neuroretinitis

GO Terms for Neuroretinitis

Cellular components related to Neuroretinitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.5 ACE CA2 CD40LG IFNB1 LYZ RNASE3
2 extracellular region GO:0005576 9.23 ACE CD40LG FLNA IFNB1 LYZ MLN

Biological processes related to Neuroretinitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 kidney development GO:0001822 9.13 ACE CA2 VEGFA
2 positive regulation of peptidyl-tyrosine autophosphorylation GO:1900086 8.62 ACE VEGFA

Sources for Neuroretinitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....